ORCA Therapeutics BV
About
ORCA Therapeutics is a clinical-stage Dutch biotech company developing best-in-class oncolytic gene therapies with enhanced anti-tumor properties. Based in Amsterdam, our proprietary engineered viruses not only selectively destroy cancer cells but uniquely transform "cold" tumors into "hot" tumors, dramatically enhancing immune system recognition and response.
Highlights:
-
Best-in-class oncolytic virus with superior anti-tumor efficacy
-
Proven immune activation - converts immunologically "cold" tumors to "hot"
-
Enhanced therapeutic properties beyond standard oncolytic approaches
-
Demonstrated clinical efficacy in completed Phase I/II trials
Innovative therapies:
Development stages and support fuctions